Subsequently, ARLTS1 variants were shown to be associated with an increased risk of several types of sporadic and familial cancers, such as prostate cancer [4], ovarian cancer [5], breast cancer [6] and other cancers [7]. This evidence concerns the gene ARL11 and ovarian carcinoma.